US Patent Issued to BEIJING YOUCARE KECHUANG PHARMACEUTICAL TECHNOLOGY on Feb. 10 for "Extrahepatic targeted cationic lipid compound with high efficiency and low toxicity and its composition" (Chinese Inventors)

ALEXANDRIA, Va., Feb. 11 -- United States Patent no. 12,545,637, issued on Feb. 10, was assigned to BEIJING YOUCARE KECHUANG PHARMACEUTICAL TECHNOLOGY Co. LTD. (Beijing).

"Extrahepatic targeted cationic lipid compound with high efficiency and low toxicity and its composition" was invented by Gengshen Song (Beijing), Honglei Zhang (Beijing), Xichao Chen (Beijing), Huanyu Wang (Beijing), Dawei Huang (Beijing), Xiaowen Yu (Beijing), Yangjian Liu (Beijing), Yuqing Li (Beijing), Rucan Yan (Beijing), Lianyong Qiao (Beijing), Xiaojuan Li (Beijing), Xiaoling Chen (Beijing), Zhenlong Sun (Beijing), Shuai Wang (Beijing), Kai Dong (Beijing) and Jinyu Zhang (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provide...